Results 251 to 260 of about 52,122 (312)

Quality of life whilst ageing in opioid agonist treatment: a narrative analysis. [PDF]

BMC Public Health
Todd-Kvam J, Sugahara G, Muller AE, Clausen T.   +3 more
europepmc   +1 more source

Psychedelics as pharmacotherapeutics for substance use disorders: A scoping review on clinical trials and perspectives on underlying neurobiology

British Journal of Pharmacology, Volume 183, Issue 14, Page 4022-4047, July 2026.
Theorized mechanism of dopamine homeostasis restoration in the nucleus accumbens core induced by a psychedelic intervention. Abstract Psychedelics have garnered great attention in recent years as treatments for major depressive disorder (MDD) and treatment‐resistant depression because of their ability to alter consciousness and afflicted cognitive ...
Lucas Wittenkeller, Gary Gudelsky, T. John Winhusen, Davide Amato   +3 more
wiley   +1 more source

Comparative effectiveness of urine drug testing schedules alongside opioid agonist treatment: Emulation of a population-based target trial in British Columbia, Canada. [PDF]

Addiction
Kurz M, Guerra-Alejos BC, Min JE, Seaman SR, Piske M, Bach P, Bruneau J, Greenland S, Gustafson P, Kampman K, Karim ME, Korthuis PT, Platt RW, Siebert U, Socías ME, Wood E, Nosyk B.   +16 more
europepmc   +1 more source

Correction: Psychiatrist-led hepatitis C (HCV) treatment at an opioid agonist treatment clinic in Stockholm- a model to enhance the HCV continuum of care. [PDF]

BMC Psychiatry
Klasa PE, Sandell M, Aleman S, Kåberg M.   +3 more
europepmc   +1 more source

Opioid Agonist Therapy Adherence Trajectories Among Commercially and Publicly Insured People Living With Hepatitis C in the United States. [PDF]

Epidemiology
Psaras C, Psaras C, Arah OA, Chew KW, Lee SJ, Javanbakht M, Nianogo RA, Seamans MJ.   +7 more
europepmc   +1 more source

Opioid analgesics for chronic noncancer pain in patients prescribed opioid agonist therapy or with opioid use disorder: A systematic review. [PDF]

Can J Pain
Ashoorion V, Sood T, Muneer S, Busse JW, Rice D, Swidrovich J, Majid U, Abesteh J, Mao RQ, Sud A.   +9 more
europepmc   +1 more source

Challenges for the implementation of injectable opioid agonist treatment: a scoping review. [PDF]

Harm Reduct J
Schwarz T, Akartuna D, Busch M, Krausz RM, Uhl A.   +4 more
europepmc   +1 more source

Short-Acting, Full Agonist Opioids During Initiation of Opioid Agonist Treatment in the Fentanyl Era

JAMA Network Open
openaire   +2 more sources

Integrated Nicotine Replacement and Behavioral Support to Reduce Smoking in Opioid Agonist Therapy: A Randomized Clinical Trial.

JAMA Psychiatry
Druckrey-Fiskaaen KT, Madebo T, Daltveit JT, Vold JH, Furulund E, Chalabianloo F, Gilje Lid T, Fadnes LT.   +7 more
europepmc   +1 more source